The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Inje University

Status: Completed

Conditions: End-stage Renal Disease

Treatments: Other: renal replacement therapy

Study type: Observational

Funder types: Other

Identifiers

NCT01612182

ESBL 2012-1

Details and patient eligibility

About

The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Enrollment: 1,289 patients

Sex: All

Ages: 18 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The age of patient was between 18 yrs and 79 yrs.
• The patient who showed Klebsiella pneumonia in 1st culture result of any site during hospitalization

Exclusion criteria

• The level of serum albumin was below 2.0 or over 5.0
• The level of AST or ALT was 2 times of normal level or the level of bilirubin was over 2.0 mg/dL during 1month.
• The level of Body mass index was below 15 or over 30
• Pregnancy

Trial design

1,289 participants in 2 patient groups

ESBL(+) Klebsiella pneumonia

Description:

All the patient who's the culture result showed ESBL(+) Klebsiella pneumonia in any site during hospitalization

Treatment:

Other: renal replacement therapy

ESBL(-) Klebsiella pneumonia

Description:

All the patient who's the culture result showed ESBL(-) Klebsiella pneumonia in any site during hospitalization

Treatment:

Other: renal replacement therapy